MERCK KGAA NAM.SP.ADR (MRKC) - Net Assets
Based on the latest financial reports, MERCK KGAA NAM.SP.ADR (MRKC) has net assets worth €28.66 Billion EUR (≈ $33.51 Billion USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€51.53 Billion ≈ $60.24 Billion USD) and total liabilities (€22.87 Billion ≈ $26.73 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check MERCK KGAA NAM.SP.ADR (MRKC) tangible net worth to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €28.66 Billion |
| % of Total Assets | 55.62% |
| Annual Growth Rate | 10.99% |
| 5-Year Change | 33.83% |
| 10-Year Change | N/A |
| Growth Volatility | 11.25 |
MERCK KGAA NAM.SP.ADR - Net Assets Trend (2020–2025)
This chart illustrates how MERCK KGAA NAM.SP.ADR's net assets have evolved over time, based on quarterly financial data. See MERCK KGAA NAM.SP.ADR defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for MERCK KGAA NAM.SP.ADR (2020–2025)
The table below shows the annual net assets of MERCK KGAA NAM.SP.ADR from 2020 to 2025. For live valuation and market cap data, see MRKC market cap overview.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | €28.66 Billion ≈ $33.51 Billion |
-4.43% |
| 2024-12-31 | €29.99 Billion ≈ $35.06 Billion |
+12.08% |
| 2023-12-31 | €26.75 Billion ≈ $31.28 Billion |
+2.88% |
| 2022-12-31 | €26.00 Billion ≈ $30.40 Billion |
+21.43% |
| 2021-12-31 | €21.42 Billion ≈ $25.04 Billion |
+25.85% |
| 2020-12-31 | €17.02 Billion ≈ $19.89 Billion |
-- |
Equity Component Analysis
This analysis shows how different components contribute to MERCK KGAA NAM.SP.ADR's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 94.2% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €24.04 Billion | 84.08% |
| Other Components | €4.55 Billion | 15.92% |
| Total Equity | €28.59 Billion | 100.00% |
MERCK KGAA NAM.SP.ADR Competitors by Market Cap
The table below lists competitors of MERCK KGAA NAM.SP.ADR ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Tourmaline Oil Corp.
TO:TOU
|
$17.08 Billion |
|
Bank of Hangzhou Co Ltd
SHG:600926
|
$17.09 Billion |
|
Falabella
SN:FALABELLA
|
$17.10 Billion |
|
Lenovo Group Limited
F:LHL1
|
$17.12 Billion |
|
mBank SA
WAR:MBK
|
$17.05 Billion |
|
Rongsheng Petrochemical Co Ltd
SHE:002493
|
$17.03 Billion |
|
China Shipbuilding Industry Co Ltd
SHG:601989
|
$17.02 Billion |
|
Telkom Indonesia (Persero) Tbk PT
JK:TLKM
|
$17.01 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in MERCK KGAA NAM.SP.ADR's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 29,912,000,000 to 28,592,000,000, a change of -1,320,000,000 (-4.4%).
- Net income of 2,608,000,000 contributed positively to equity growth.
- Dividend payments of 284,000,000 reduced retained earnings.
- Other factors decreased equity by 3,644,000,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €2.61 Billion | +9.12% |
| Dividends Paid | €284.00 Million | -0.99% |
| Other Changes | €-3.64 Billion | -12.74% |
| Total Change | €- | -4.41% |
Book Value vs Market Value Analysis
This analysis compares MERCK KGAA NAM.SP.ADR's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.34x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 0.58x to 0.34x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-12-31 | €38.98 | €22.60 | x |
| 2021-12-31 | €49.08 | €22.60 | x |
| 2022-12-31 | €59.63 | €22.60 | x |
| 2023-12-31 | €61.36 | €22.60 | x |
| 2024-12-31 | €68.80 | €22.60 | x |
| 2025-12-31 | €65.76 | €22.60 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently MERCK KGAA NAM.SP.ADR utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 9.12%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 12.36%
- • Asset Turnover: 0.41x
- • Equity Multiplier: 1.80x
- Recent ROE (9.12%) is below the historical average (11.31%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | 11.73% | 11.33% | 0.42x | 2.47x | €292.40 Million |
| 2021 | 14.32% | 15.52% | 0.43x | 2.13x | €921.20 Million |
| 2022 | 12.83% | 14.96% | 0.46x | 1.87x | €733.30 Million |
| 2023 | 10.58% | 13.45% | 0.43x | 1.82x | €156.00 Million |
| 2024 | 9.28% | 13.13% | 0.41x | 1.72x | €-214.20 Million |
| 2025 | 9.12% | 12.36% | 0.41x | 1.80x | €-251.20 Million |
Industry Comparison
This section compares MERCK KGAA NAM.SP.ADR's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $6,888,924,775
- Average return on equity (ROE) among peers: -44.00%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| MERCK KGAA NAM.SP.ADR (MRKC) | €28.66 Billion | 11.73% | 0.80x | $17.07 Billion |
| SHANG.FOS.PHARM.GR.H YC 1 (08HH) | $61.84 Billion | 5.45% | 0.94x | $1.13 Billion |
| PEPTONIC MEDICAL (28L) | $47.09 Million | -78.27% | 0.82x | $4.14 Million |
| Tianjin Zhong Xin Pharmaceutical Group Corporation Limited (2TZ) | $6.55 Billion | 13.15% | 0.55x | $692.11 Million |
| WEST ISLAND BRANDS INC. (39N0) | $3.27 Million | -157.21% | 0.88x | $1.34 Million |
| AYURCANN HOLDINGS CORP. (3ZQ0) | $2.69 Million | -197.11% | 3.73x | $97.35K |
| CERENO SCIENTIFIC AB B (4A1) | $216.42 Million | -22.23% | 0.32x | $157.72 Million |
| MAPLE LEAF GREEN WORLD (4HV0) | $-9.91 Million | 0.00% | 0.00x | $504.30K |
| LORDS CO. WORLDW. HOLD. (4XM) | $-1.01 Million | 0.00% | 0.00x | $134.78K |
| RED LIGHT HOLLAND CORP. (4YX) | $17.35 Million | -23.30% | 0.22x | $13.93 Million |
| EQL PHARMA AB (7JK) | $221.03 Million | 19.51% | 2.66x | $78.37 Million |
About MERCK KGAA NAM.SP.ADR
Merck KGaA operates as a science and technology company in Germany and internationally. It operates through Life Science, Healthcare, and Electronics segments. The Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as the industrial sector. This segment offers science and lab solutions comprising reagents, consumables,… Read more